These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9029084)
1. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. Deng Y; Yewdell JW; Eisenlohr LC; Bennink JR J Immunol; 1997 Feb; 158(4):1507-15. PubMed ID: 9029084 [TBL] [Abstract][Full Text] [Related]
2. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D. Mata M; Travers PJ; Liu Q; Frankel FR; Paterson Y J Immunol; 1998 Sep; 161(6):2985-93. PubMed ID: 9743362 [TBL] [Abstract][Full Text] [Related]
3. Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. Sandberg JK; Grufman P; Wolpert EZ; Franksson L; Chambers BJ; Kärre K J Immunol; 1998 Apr; 160(7):3163-9. PubMed ID: 9531271 [TBL] [Abstract][Full Text] [Related]
4. Immunodominance does not result from peptide competition for MHC class II presentation. Lo-Man R; Langeveld JP; Martineau P; Hofnung M; Meloen RH; Leclerc C J Immunol; 1998 Feb; 160(4):1759-66. PubMed ID: 9469434 [TBL] [Abstract][Full Text] [Related]
5. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance. Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207 [TBL] [Abstract][Full Text] [Related]
6. Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model. Gapin L; Bravo de Alba Y; Casrouge A; Cabaniols JP; Kourilsky P; Kanellopoulos J J Immunol; 1998 Feb; 160(4):1555-64. PubMed ID: 9469410 [TBL] [Abstract][Full Text] [Related]
7. Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. Vitiello A; Yuan L; Chesnut RW; Sidney J; Southwood S; Farness P; Jackson MR; Peterson PA; Sette A J Immunol; 1996 Dec; 157(12):5555-62. PubMed ID: 8955206 [TBL] [Abstract][Full Text] [Related]
8. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. Anton LC; Yewdell JW; Bennink JR J Immunol; 1997 Mar; 158(6):2535-42. PubMed ID: 9058784 [TBL] [Abstract][Full Text] [Related]
9. High peptide affinity for MHC class I does not correlate with immunodominance. Müllbacher A; Lobigs M; Yewdell JW; Bennink JR; Tha Hla R; Blanden RV Scand J Immunol; 1999 Oct; 50(4):420-6. PubMed ID: 10520183 [TBL] [Abstract][Full Text] [Related]
10. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo. Ma H; Kapp JA Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833 [TBL] [Abstract][Full Text] [Related]
11. Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model. Grunhaus A; Cho S; Horwitz MS Virology; 1994 May; 200(2):535-46. PubMed ID: 8178441 [TBL] [Abstract][Full Text] [Related]
12. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties. Bristol JA; Schlom J; Abrams SI J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787 [TBL] [Abstract][Full Text] [Related]
13. Assembly of MHC class I molecules with biosynthesized endoplasmic reticulum-targeted peptides is inefficient in insect cells and can be enhanced by protease inhibitors. Deng Y; Gibbs J; Bacík I; Porgador A; Copeman J; Lehner P; Ortmann B; Cresswell P; Bennink JR; Yewdell JW J Immunol; 1998 Aug; 161(4):1677-85. PubMed ID: 9712031 [TBL] [Abstract][Full Text] [Related]
14. Protection against lethal viral infection by vaccination with nonimmunodominant peptides. Oukka M; Manuguerra JC; Livaditis N; Tourdot S; Riche N; Vergnon I; Cordopatis P; Kosmatopoulos K J Immunol; 1996 Oct; 157(7):3039-45. PubMed ID: 8816413 [TBL] [Abstract][Full Text] [Related]
15. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein. Lukacher AE; Wilson CS J Immunol; 1998 Feb; 160(4):1724-34. PubMed ID: 9469430 [TBL] [Abstract][Full Text] [Related]
16. Immunodominance of a single CTL epitope in a primate species with limited MHC class I polymorphism. Evans DT; Piekarczyk MS; Allen TM; Boyson JE; Yeager M; Hughes AL; Gotch FM; Hinshaw VS; Watkins DI J Immunol; 1997 Aug; 159(3):1374-82. PubMed ID: 9233634 [TBL] [Abstract][Full Text] [Related]
17. Dominance of a single peptide bound to the class I(B) molecule, Qa-1b. DeCloux A; Woods AS; Cotter RJ; Soloski MJ; Forman J J Immunol; 1997 Mar; 158(5):2183-91. PubMed ID: 9036964 [TBL] [Abstract][Full Text] [Related]
18. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. Antón LC; Snyder HL; Bennink JR; Vinitsky A; Orlowski M; Porgador A; Yewdell JW J Immunol; 1998 May; 160(10):4859-68. PubMed ID: 9590233 [TBL] [Abstract][Full Text] [Related]
19. MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL. Busch DH; Pamer EG J Immunol; 1998 May; 160(9):4441-8. PubMed ID: 9574549 [TBL] [Abstract][Full Text] [Related]
20. Identification of MHC class I H-2 Kb/Db-restricted immunogenic peptides derived from retinal proteins. Wang M; Bai F; Pries M; Buus S; Prause JU; Nissen MH Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3939-45. PubMed ID: 16936108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]